U
Eikon Therapeutics, Inc. EIKN
$15.05 $0.221.48% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024
Total Cash And Short-Term Investments 220.11M
Total Receivables --
Inventory --
Prepaid Expenses 7.38M
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets 400.00K
Total Current Assets 227.89M

Total Current Assets 227.89M
Net Property, Plant & Equipment 259.13M
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets 4.22M
Total Assets 491.24M

Total Accounts Payable 17.58M
Total Accrued Expenses 29.16M
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current 9.31M
Total Finance Division Other Current Liabilities 404.00K
Total Other Current Liabilities 404.00K
Total Current Liabilities 56.45M

Total Current Liabilities 56.45M
Long-Term Debt --
Short-term Debt --
Capital Leases 193.15M
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities 5.35M
Total Liabilities 254.95M

Common Stock & APIC 33.01M
Retained Earnings -604.94M
Treasury Stock & Other --
Total Common Equity -571.93M

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible 808.22M
Preferred Stock, Others --
Total Preferred Equity 808.22M

Total Common Equity -571.93M
Total Preferred Equity 808.22M
Total Minority Interest --
Total Equity 236.29M